Skip to main content
. 2025 Jul 1;42(4):321–328. doi: 10.4274/balkanmedj.galenos.2025.2025-4-90

TABLE 2. Outcomes in the Study Arms.

Outcome (n = 148)

Cutting needle(n = 73)

n (%)

Abrams needle(n = 75)

n (%)

p

False negative (n = 43, 29.0%)

Diffuse pleural mesothelioma ( n= 21)

Metastatic malignant pleural diseases (n = 20)

Tuberculous pleurisy (n = 2)

-

True positive (n = 68, 45.9%)

Diffuse pleural mesothelioma (n = 15)

Metastatic malignant pleural diseases (n = 49)

Tuberculous pleurisy (n = 4)

-

True negative (other benign diseases) (n = 37, 25.1%)

27/73 (36.9)

12/19 (63.2)

14/36 (38.9)

1/3 (33.3)

-

31/73 (42.5)

7/19 (36.8)

22 /36 (61.1)

2/3 (66.7)

-

15/73 (20.5)

16/75 (21.3)

9/17 (52.9)

6/33 (18.2)

1/3 (33.3)

-

37/75 (49.3)

8/17 (47.1)

27/33 (81.8)

2/3 (66.7)

-

22/75 (29.3)

0.036

-

-

-

-

0.698

-

-

-

-

0.218